Browsing: COVID-19

48-2 PPE Redistribution.png
COVID-19

Taking Action When the Tides Turn: Medical Student-Led PPE Redistribution During the COVID-19 Pandemic

4/9/2021 Hannah Day, MS
When COVID-19 disrupted their medical training, medical students around the nation sought ways to help, from forming childcare networks to organizing drives for personal protective equipment. This art
48-2 COVID Airway.png
COVID-19 , Airway , Critical Care , Ventilator Management

Management of the COVID-19 Airway

4/8/2021 Connor Greer, MD , Robert Razick , Joel Hamm, MD, FACEP
There are many perspectives available and early data to guide management of COVID-19 patients who present with respiratory failure. This article will review practice-altering data and the approach use
48-2 President Message.jpg
President's Message , Match , COVID-19

Class of 2022, We're Here for You

4/8/2021 RJ Sontag, MD
As the COVID-19 pandemic evolves in 2021, major EM groups have once again stepped up to provide a unified roadmap to the away rotation and eSLOE process. Class of 2022, your training may look differe
48-2 Kawasaki or MIS-C.png
COVID-19 , Pediatric EM , Cardiology

Kawasaki Disease or MIS-C?

4/8/2021 Blair Gaines, MD
Clinical knowledge regarding how the COVID-19 virus affects children is still evolving. Multisystem Inflammatory Syndrome in Children (MIS-C) can be approached in the same way as a Kawasaki-Like Hyper
CCA-HOT ICU.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure (The HOT-ICU Trial)

3/22/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD
The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
CCA-Receptor Antagonists.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Interleukin-6 Antagonists in Critically Ill Patients with COVID-19

3/18/2021 Oswald Reid, Jr., MD , Brian Sumner, MD
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
CCA-Tocilizumab.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY)

3/18/2021 Taylor Miller, MD , Brian Sumner, MD
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.
hpjc-0321.jpg
Health Policy Journal Club , Health Policy , Advocacy , COVID-19

Health Policy Journal Club: Patient Visits Plummet During Pandemic

3/6/2021 Clinton Lam , Cedric Dark, MD, MPH, FACEP
A recent study investigated COVID-19's impact on hospital visits. Patient volume plummeted - disproportionately affecting populations that already struggle with systemic inequities in healthcare.
COVID anxiety study.jpg
COVID-19 , Research

Assessing COVID-related Anxiety Among Emergency Medicine Physicians and Residents in a NY Hospital During and After the Peak of the COVID-19 Pandemic

2/5/2021 Lauren DeMaris, DO
With levels of COVID increasing globally, the full impact of the pandemic on the mental health of frontline workers is still to be determined. This study sought to assess emergency medicine (EM) physi
COVID night shift.jpg
COVID-19 , Heart of EM

CODE BLUE: An Intern's Reflections from Nights in the COVID-19 ICU

2/5/2021 Benjamen Schoenberg, MD
How could you truly know what it's like in the intensive care unit or emergency department during the peak of the SARS-CoV-2 pandemic without experiencing it yourself? As a new emergency medicine resi